Internal Medicine · Bloomfield, NJ
NPI
1265540686
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
382 W Passaic Ave
Bloomfield, NJ, 07003
Phone (973) 338-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$486K
9,434 services
Medicare patients, 2024
617
Average age 73
Drug cost, 2024
$1.0M
9,771 prescriptions
Company payments, 2025
$877
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Kelly was code 99490 (chronic, principal, and transitional care management), 3,323 times for 380 patients. In total John Kelly billed 9,434 services in 68 codes, and Medicare paid $486K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,323 | 380 | $47.84 | $159K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,014 | 122 | $0.08 | $85.58 |
| 99214 Office E&M - Established | Office | 738 | 321 | $102.88 | $76K |
| 99212 Office E&M - Established | Office | 443 | 345 | $43.00 | $19K |
| 81002 Clinical Chemistry | Office | 425 | 347 | $3.41 | $1,449 |
| 99213 Office E&M - Established | Office | 398 | 217 | $73.27 | $29K |
| 93000 Electrocardiogram | Office | 367 | 344 | $11.10 | $4,075 |
| 99232 Hospital E&M - Subsequent | Facility | 362 | 76 | $66.35 | $24K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 308 | 308 | $141.76 | $44K |
| 99233 Hospital E&M - Subsequent | Facility | 297 | 108 | $99.05 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 288 | 196 | $13.11 | $3,774 |
| 96372 Injection Administration | Office | 188 | 130 | $11.81 | $2,220 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 164 | 140 | $33.81 | $5,545 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 136 | 136 | $20.93 | $2,847 |
| 99223 Hospital E&M - Initial | Facility | 129 | 106 | $142.32 | $18K |
By year: 2022 $608K for 11,171 services; 2023 $612K for 11,322 services; 2024 $486K for 9,434 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 425 | 347 | $3.41 | $1,449 |
| 87426 Immunoassay | 91 | 83 | $34.62 | $3,150 |
| 87502 Infectious Agent Detection by DNA/RNA | 40 | 38 | $79.61 | $3,185 |
Medicare prescription drug claims, 2024
In 2024, the drug John Kelly prescribed most often to Medicare patients was Atorvastatin Calcium, with 659 prescriptions and refills. In total John Kelly wrote 9,771 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 659 | 1,456 | 199 | $7,062 |
| Amlodipine Besylate Generic | 505 | 1,233 | 168 | $3,325 |
| Metformin Hcl Generic | 295 | 698 | 82 | $2,575 |
| Levothyroxine Sodium Generic | 272 | 652 | 78 | $2,695 |
| Metoprolol Succinate Generic | 222 | 521 | 72 | $2,492 |
| Omeprazole Generic | 198 | 453 | 69 | $2,060 |
| Losartan Potassium Generic | 192 | 472 | 60 | $2,044 |
| Alprazolam Generic | 180 | 191 | 44 | $1,305 |
| Trazodone Hcl Generic | 164 | 245 | 51 | $934 |
| Rosuvastatin Calcium Generic | 162 | 418 | 61 | $1,972 |
| Gabapentin Generic | 162 | 192 | 51 | $1,724 |
| Azithromycin Generic | 161 | 161 | 134 | $558 |
| Furosemide Generic | 151 | 265 | 56 | $691 |
| Hydrochlorothiazide Generic | 140 | 362 | 46 | $537 |
| Methylprednisolone Generic | 133 | 133 | 115 | $943 |
Brand drugs: 1,269 claims; generic drugs: 8,450 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Kelly $877 ($877 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $253.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $253 |
| Pfizer Inc. PFE | 6 | $98.34 |
| Novo Nordisk Inc NVO | 6 | $96.26 |
| Exact Sciences Corporation EXAS | 3 | $80.45 |
| Lilly USA, LLC LLY | 3 | $53.11 |
| Stryker Corporation SYK | 1 | $52.27 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47.71 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $42.93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $34.41 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $17.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.